Vikram Gota

825 total citations
45 papers, 253 citations indexed

About

Vikram Gota is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Vikram Gota has authored 45 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Vikram Gota's work include Lung Cancer Treatments and Mutations (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Vikram Gota is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Vikram Gota collaborates with scholars based in India, United Kingdom and United States. Vikram Gota's co-authors include Shripad Banavali, Anand Patil, Murari Gurjar, Kumar Prabhash, C. S. Ramaa, C. Murali Krishna, Sadhana Kannan, Manju Sengar, Gaurav Narula and Amit Joshi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vikram Gota

39 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikram Gota India 11 70 49 48 46 38 45 253
Sonia Khier France 12 116 1.7× 49 1.0× 28 0.6× 38 0.8× 43 1.1× 22 422
Uche Anadu Ndefo United States 10 88 1.3× 91 1.9× 28 0.6× 88 1.9× 18 0.5× 21 447
Isabelle Solassol France 10 103 1.5× 84 1.7× 50 1.0× 20 0.4× 38 1.0× 17 328
Chengda Zhang China 14 125 1.8× 39 0.8× 64 1.3× 22 0.5× 19 0.5× 49 553
Michael Elsässer Germany 10 84 1.2× 26 0.5× 35 0.7× 50 1.1× 41 1.1× 15 276
Simone von Bonin Germany 6 104 1.5× 142 2.9× 54 1.1× 22 0.5× 34 0.9× 10 429
Jean‐François Tournamille France 10 75 1.1× 108 2.2× 68 1.4× 21 0.5× 19 0.5× 20 315
Guillaume Becker France 8 68 1.0× 49 1.0× 20 0.4× 20 0.4× 17 0.4× 19 227

Countries citing papers authored by Vikram Gota

Since Specialization
Citations

This map shows the geographic impact of Vikram Gota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Gota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Gota more than expected).

Fields of papers citing papers by Vikram Gota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Gota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Gota. The network helps show where Vikram Gota may publish in the future.

Co-authorship network of co-authors of Vikram Gota

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram Gota. A scholar is included among the top collaborators of Vikram Gota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram Gota. Vikram Gota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dasgupta, Archya, Vikram Gota, Ameya Puranik, et al.. (2025). Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME). Cancer Medicine. 14(5). e70657–e70657. 1 indexed citations
2.
Mukherjee, Aparna, Tejpal Gupta, Bikash Medhi, et al.. (2025). Increasing early phase clinical trials capacity in India. Communications Medicine. 5(1). 255–255.
3.
Noronha, Vanita, et al.. (2024). Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 94(5). 659–668. 2 indexed citations
4.
Singh, Beena G., et al.. (2023). Preparation of protein nanoparticles using diselenide functionalized gelatin for redox responsive release of doxorubicin. Journal of Drug Delivery Science and Technology. 92. 105281–105281. 3 indexed citations
5.
Gota, Vikram, Renita Castelino, Sharath Kumar, et al.. (2023). Comparison of glomerular filtration rate estimating equations in Indian geriatric patients with cancer.. Journal of Clinical Oncology. 41(16_suppl). e24025–e24025.
6.
Joshi, Amit, Murari Gurjar, Pallavi Rane, et al.. (2022). Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer. Cancer Chemotherapy and Pharmacology. 89(6). 751–759. 6 indexed citations
7.
Dhamne, Chetan, Pallavi Rane, Murari Gurjar, et al.. (2022). A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL). Cancer Chemotherapy and Pharmacology. 90(6). 445–453. 1 indexed citations
8.
Sengar, Manju, Hasmukh Jain, Sadhana Kannan, et al.. (2022). Exposure-Response Relationship of Posaconazole Suspension in Theprophylaxis of Invasive Fungal Infections in Patients with Acute Myeloid Leukemia. Indian Journal of Hematology and Blood Transfusion. 39(2). 200–207. 1 indexed citations
9.
Noronha, Vanita, Anant Ramaswamy, Shreya Gattani, et al.. (2022). The prevalence of cognitive impairment in older Indian persons with cancer and brain metastases. ecancermedicalscience. 16. 1372–1372. 2 indexed citations
10.
Hingorani, Lal, et al.. (2021). Pharmacokinetics of solid lipid Boswellia serrata particles in healthy subjects. Drug Metabolism and Personalized Therapy. 36(3). 215–221. 2 indexed citations
11.
Tandon, Sneha, et al.. (2021). Role of Therapeutic Drug Monitoring and Challenges in the Management of Infantile Chronic Myeloid Leukemia. Pediatric Oncall. 18(2). 1 indexed citations
12.
13.
Gota, Vikram, et al.. (2018). Quality of informed consent in cancer clinical trials in India: A cross-sectional survey. The National Medical Journal of India. 31(6). 334–334. 6 indexed citations
14.
15.
Shukla, Anil Kumar, Rajesh Kumar Singh, Vikash Kumar Dubey, et al.. (2016). Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis. AAPS PharmSciTech. 18(3). 710–720. 10 indexed citations
16.
Gota, Vikram, Girish Chinnaswamy, Tushar Vora, et al.. (2016). Pharmacokinetics and pharmacogenetics of 13-cis retinoic acid in Indian high-risk neuroblastoma patients. Cancer Chemotherapy and Pharmacology. 78(4). 763–768. 4 indexed citations
17.
Pandey, Usha, et al.. (2015). Synthesis and Preclinical Evaluation of 177 Lu-CHX-A”-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 30(6). 240–246. 18 indexed citations
18.
Gota, Vikram, et al.. (2015). Biodistribution and Pharmacokinetic Study of 3,3′ Diseleno Dipropionic Acid (DSePA), A Synthetic Radioprotector, in Mice. European Journal of Drug Metabolism and Pharmacokinetics. 41(6). 839–844. 15 indexed citations
20.
Gota, Vikram, et al.. (2011). Off-label use of anti-cancer drugs in India: To be or not to be!. Journal of Cancer Research and Therapeutics. 7(1). 35–35. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026